HomeInsightsStock Comparison

Astonea Labs Ltd vs Bal Pharma Ltd Stock Comparison

Astonea Labs Ltd vs Bal Pharma Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Astonea Labs Ltd is ₹ 141.25 as of 13 Jun 15:30.
  • The P/E Ratio of Astonea Labs Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Bal Pharma Ltd changed from 16.8 on March 2021 to 19.5 on March 2024 . This represents a CAGR of 3.80% over 4 years.
  • The Market Cap of Astonea Labs Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Bal Pharma Ltd changed from ₹ 46.13 crore on March 2020 to ₹ 144.21 crore on March 2024 . This represents a CAGR of 25.60% over 5 years.
  • The revenue of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bal Pharma Ltd for the Mar '25 is ₹ 82.96 crore as compare to the Dec '24 revenue of ₹ 73.66 crore. This represent the growth of 12.63%.
  • The ebitda of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Bal Pharma Ltd for the Mar '25 is ₹ 8.72 crore as compare to the Dec '24 ebitda of ₹ 8.26 crore. This represent the growth of 5.57%.
  • The net profit of Astonea Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Bal Pharma Ltd changed from ₹ 0.09 crore to ₹ 5.42 crore over 8 quarters. This represents a CAGR of 676.03% .
  • The Dividend Payout of Astonea Labs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Bal Pharma Ltd changed from 16.29 % on March 2021 to 18.46 % on March 2024 . This represents a CAGR of 3.18% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astonea Labs Ltd

  • Astonea Labs Ltd was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
  • Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
  • Subsequently, the Company converted into 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024. Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
  • These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
  • These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.

About Bal Pharma Ltd

  • Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87.
  • In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
  • The company promotes its products through the common sales force of the group but proposes to induct its own soon.
  • It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited.

Astonea Labs Ltd News Hub

News

BSE SME Astonea Labs inches higher on debut

The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public off...

Read more

03 Jun 2025 11:01

Bal Pharma Ltd News Hub

News

Board of Bal Pharma recommends final dividend

Bal Pharma announced that the Board of Directors of the Company at its meeting held on 29 ...

Read more

30 May 2025 11:20

News

Bal Pharma to declare Quarterly Results

Bal Pharma will hold a meeting of the Board of Directors of the Company on 29 May 2025. Po...

Read more

17 May 2025 11:42

News

Bal Pharma Ltd leads gainers in 'B' group

Chemcrux Enterprises Ltd, Maral Overseas Ltd, Growington Ventures India Ltd and Orchasp Lt...

Read more

03 Apr 2025 12:15

News

Bal Pharma to hold board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 13 February 202...

Read more

25 Jan 2025 10:17

News

Bal Pharma schedules board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 14 November 202...

Read more

06 Nov 2024 20:13

News

Bal Pharma to convene board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 202...

Read more

31 Aug 2024 10:27

SWOT Analysis Of Bal Pharma Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Bal Pharma Ltd

Which company has a larger market capitalization, Astonea Labs Ltd or Bal Pharma Ltd?

Market cap of Astonea Labs Ltd is 148 Cr while Market cap of Bal Pharma Ltd is 164 Cr

What are the key factors driving the stock performance of Astonea Labs Ltd and Bal Pharma Ltd?

The stock performance of Astonea Labs Ltd and Bal Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astonea Labs Ltd and Bal Pharma Ltd?

As of June 14, 2025, the Astonea Labs Ltd stock price is INR ₹141.25. On the other hand, Bal Pharma Ltd stock price is INR ₹103.33.

How do dividend payouts of Astonea Labs Ltd and Bal Pharma Ltd compare?

To compare the dividend payouts of Astonea Labs Ltd and Bal Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions